HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.

Abstract
During erythropoiesis, erythropoietin stimulates induction of erythroid transcription factors that activate expression of erythroid genes including the erythropoietin receptor (EPO-R) that results in increased sensitivity to erythropoietin. DNA binding of the basic helix-loop-helix transcription factor, TAL1/SCL, is required for normal erythropoiesis. A link between elevated TAL1 and excessive erythrocytosis is suggested by erythroid progenitor cells from a patient that exhibits unusually high sensitivity to erythropoietin with concomitantly elevated TAL1 and EPO-R expression. We found that TAL1 regulates EPO-R expression mediated via three conserved E-box binding motifs (CAGCTG) in the EPO-R 5' untranslated transcribed region. TAL1 increases association of the GATA-1·TAL1·LMO2·LDB1 transcription activation complex to the region that includes the transcription start site and the 5' GATA and 3' E-box motifs flanking the EPO-R transcription start site suggesting that TAL1 promotes accessibility of this region. Nucleosome shifting has been demonstrated to facilitate TAL1 but not GATA-1 binding to regulate target gene expression. Accordingly, we observed that with induced expression of EPO-R in hemotopoietic progenitor cells, nucleosome phasing shifts to increase the linker region containing the EPO-R transcription start site and TAL1 binds to the flanking 5' GATA and 3' E-box regions of the promoter. These data suggest that TAL1 binds to the EPO-R promoter to activate EPO-R expression and provides a potential link to elevated EPO-R expression leading to hypersensitivity to erythropoietin and the resultant excessive erythrocytosis.
AuthorsHeather Rogers, Li Wang, Xiaobing Yu, Mawadda Alnaeeli, Kairong Cui, Keji Zhao, James J Bieker, Josef Prchal, Suming Huang, Babette Weksler, Constance Tom Noguchi
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 287 Issue 44 Pg. 36720-31 (Oct 26 2012) ISSN: 1083-351X [Electronic] United States
PMID22982397 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Antigens, CD
  • Basic Helix-Loop-Helix Transcription Factors
  • EPO protein, human
  • GATA1 Transcription Factor
  • GATA1 protein, human
  • GATA2 Transcription Factor
  • GATA2 protein, human
  • Kruppel-Like Transcription Factors
  • Proto-Oncogene Proteins
  • Receptors, Erythropoietin
  • T-Cell Acute Lymphocytic Leukemia Protein 1
  • beta-Globins
  • erythroid Kruppel-like factor
  • Erythropoietin
  • TAL1 protein, human
  • Luciferases, Renilla
  • JAK2 protein, human
  • Janus Kinase 2
Topics
  • Adult
  • Antigens, CD (metabolism)
  • Basic Helix-Loop-Helix Transcription Factors (metabolism)
  • Binding Sites
  • Case-Control Studies
  • Cell Differentiation
  • Cell Proliferation
  • Cells, Cultured
  • DNA Mutational Analysis
  • Erythroid Cells (metabolism)
  • Erythropoietin (physiology)
  • GATA1 Transcription Factor (genetics, metabolism)
  • GATA2 Transcription Factor (genetics, metabolism)
  • Gene Expression
  • Gene Expression Regulation
  • Genes, Reporter
  • Hematopoietic Stem Cells (metabolism)
  • Humans
  • Janus Kinase 2 (genetics)
  • Kruppel-Like Transcription Factors (genetics, metabolism)
  • Luciferases, Renilla (biosynthesis, genetics)
  • Male
  • Mutation, Missense
  • Polycythemia (genetics, metabolism, pathology)
  • Promoter Regions, Genetic
  • Protein Binding
  • Proto-Oncogene Proteins (metabolism)
  • Receptors, Erythropoietin (genetics, metabolism)
  • T-Cell Acute Lymphocytic Leukemia Protein 1
  • beta-Globins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: